Patents by Inventor David Wargo

David Wargo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150141220
    Abstract: An exercise ball having a transparent water level indicating system is disclosed. The exercise ball has a liquid impermeable shell which creates an interior chamber and forms a covering surface for the exercise ball. The interior chamber is filled with a fluid such as water through a valve provided on the liquid impermeable shell. The valve includes an air tight closure which prevents the leakage of the fluid during exercise. A transparent portion provided on the liquid impermeable shell of the exercise ball indicates a level of the fluid filled within the interior chamber. The transparent portion includes a plurality of markings for providing direct indication of a weight of the exercise ball. A user can directly view the level of the fluid filled in the exercise ball and thereby can read a present weight of the exercise ball with the fluid.
    Type: Application
    Filed: November 18, 2013
    Publication date: May 21, 2015
    Inventor: David Wargo
  • Publication number: 20070122476
    Abstract: This invention provides a storage-stable dosage form of a thyroxine active drug composition which exhibits an improved stability. The formulation contains a thyroxine active drug substance, an alditol, and a saccharide, and, optionally, additional pharmaceutically accepted excipients. Levothyroxine sodium is the preferred active drug substance, mannitol is the preferred alditol, and sucrose is the9 preferred saccharide. Additional preferred excipients include, for example, microcrystalline cellulose, crospovidone, magnesium stearate, colloidal silicon dioxide, and sodium lauryl sulfate.
    Type: Application
    Filed: January 30, 2007
    Publication date: May 31, 2007
    Applicant: Mylan Pharmaceuticals Inc.
    Inventors: Dwight Hanshew, David Wargo
  • Publication number: 20050232991
    Abstract: This invention provides a storage-stable dosage form of a thyroxine active drug composition which exhibits an improved stability. The formulation contains a thyroxine active drug substance, an alditol, and a saccharide, and, optionally, additional pharmaceutically accepted excipients. Levothyroxine sodium is the preferred active drug substance, mannitol is the preferred alditol, and sucrose is the9 preferred saccharide. Additional preferred excipients include, for example, microcrystalline cellulose, crospovidone, magnesium stearate, colloidal silicon dioxide, and sodium lauryl sulfate.
    Type: Application
    Filed: June 3, 2005
    Publication date: October 20, 2005
    Inventors: Dwight Hanshew, David Wargo